C.‐B. Laurell

11.8k total citations · 4 hit papers
104 papers, 8.6k citations indexed

About

C.‐B. Laurell is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, C.‐B. Laurell has authored 104 papers receiving a total of 8.6k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 18 papers in Hematology and 16 papers in Cancer Research. Recurrent topics in C.‐B. Laurell's work include Protease and Inhibitor Mechanisms (14 papers), Monoclonal and Polyclonal Antibodies Research (12 papers) and Peptidase Inhibition and Analysis (10 papers). C.‐B. Laurell is often cited by papers focused on Protease and Inhibitor Mechanisms (14 papers), Monoclonal and Polyclonal Antibodies Research (12 papers) and Peptidase Inhibition and Analysis (10 papers). C.‐B. Laurell collaborates with scholars based in Sweden, United States and Germany. C.‐B. Laurell's co-authors include Sten Eriksson, Hans Lilja, Magne K. Fagerhol, K. Ohlsson, Gunnar Rannevik, J. Oldbring, Bo Franzén, K. F. Aronsen, G. Ekelund and Stig Kullander and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

C.‐B. Laurell

103 papers receiving 7.5k citations

Hit Papers

Electroimmuno Assay 1963 2026 1984 2005 1972 1965 1963 1972 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C.‐B. Laurell Sweden 38 2.5k 1.6k 1.5k 1.4k 1.1k 104 8.6k
Carl‐Bertil Laurell Sweden 21 2.1k 0.8× 1.4k 0.9× 967 0.6× 1.1k 0.8× 575 0.5× 42 6.6k
C R Minick United States 25 3.1k 1.2× 1.2k 0.8× 1.2k 0.8× 640 0.4× 563 0.5× 33 8.8k
C. Haanen Netherlands 36 4.0k 1.6× 1.6k 1.0× 633 0.4× 655 0.5× 1.7k 1.5× 199 9.6k
Hans Prydz Norway 44 3.2k 1.3× 2.1k 1.3× 632 0.4× 714 0.5× 368 0.3× 205 7.1k
Edith E. Parris United States 14 5.4k 2.1× 398 0.3× 2.8k 1.8× 1.3k 0.9× 2.5k 2.3× 21 10.0k
W. Pruzanski Canada 41 2.7k 1.1× 1.1k 0.7× 407 0.3× 402 0.3× 708 0.7× 218 6.6k
Jacek Hawiger United States 42 2.5k 1.0× 1.8k 1.1× 1.1k 0.7× 1.1k 0.7× 633 0.6× 125 7.2k
Robert L. Baehner United States 49 2.3k 0.9× 1.1k 0.7× 263 0.2× 996 0.7× 785 0.7× 186 9.2k
Walter Kisiel United States 57 3.1k 1.2× 6.6k 4.2× 1.7k 1.1× 1.3k 0.9× 687 0.6× 165 11.1k
Thomas S. Edgington United States 65 4.0k 1.6× 6.0k 3.9× 2.4k 1.5× 1.7k 1.2× 1.2k 1.1× 204 14.4k

Countries citing papers authored by C.‐B. Laurell

Since Specialization
Citations

This map shows the geographic impact of C.‐B. Laurell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.‐B. Laurell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.‐B. Laurell more than expected).

Fields of papers citing papers by C.‐B. Laurell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.‐B. Laurell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.‐B. Laurell. The network helps show where C.‐B. Laurell may publish in the future.

Co-authorship network of co-authors of C.‐B. Laurell

This figure shows the co-authorship network connecting the top 25 collaborators of C.‐B. Laurell. A scholar is included among the top collaborators of C.‐B. Laurell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C.‐B. Laurell. C.‐B. Laurell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rannevik, Gunnar, et al.. (1996). Plasma protein changes induced by two orally administered androgen derivatives. Scandinavian Journal of Clinical and Laboratory Investigation. 56(2). 161–166. 8 indexed citations
2.
Laurell, C.‐B., et al.. (1994). The pregnancy zone protein response during gestation: A metabolic challenge. Scandinavian Journal of Clinical and Laboratory Investigation. 54(8). 623–629. 16 indexed citations
3.
Baumann, Ulrich, et al.. (1991). Crystal structure of cleaved human α1-antichymotrypsin at 2.7 å resolution and its comparison with other serpins. Journal of Molecular Biology. 218(3). 595–606. 148 indexed citations
4.
Persson, Per‐Håkan, Stig Kullander, G. Gennser, Lars Grennert, & C.‐B. Laurell. (1983). Screening for fetal malformations using ultrasound and measurements of alpha-fetoprotein in maternal serum.. BMJ. 286(6367). 747–749. 26 indexed citations
5.
Jacobson, Lennart, et al.. (1975). Plasma Protein Changes Induced by Acute Inflammation of the Fallopian Tubes. International Journal of Gynecology & Obstetrics. 13(6). 249–256. 8 indexed citations
6.
Laurell, C.‐B. & Eva Thulin. (1975). Thiol-disulfide interchange in the binding of bence jones proteins to alpha-antitrypsin, prealbumin, and albumin.. The Journal of Experimental Medicine. 141(2). 453–465. 23 indexed citations
7.
Laurell, C.‐B., et al.. (1974). α1,‐ANTITRYPSIN DEFICIENCY Pi Genotype ZO, SO und MO. Acta Paediatrica. 63(6). 855–857. 15 indexed citations
8.
Jeppsson, Sten, C.‐B. Laurell, & Gunnar Rannevik. (1973). Plasma Proteins after Use of Estrogen and/or Progestogen in Women with and without Recurrent Cholestasis during Previous Pregnancies. Scandinavian Journal of Clinical and Laboratory Investigation. 31(1). 33–36. 9 indexed citations
9.
Laurell, C.‐B., et al.. (1972). Plasma Protein Pattern in Cirrhosis of the Liver. Scandinavian Journal of Clinical and Laboratory Investigation. 29(sup124). 97–103. 45 indexed citations
10.
Laurell, C.‐B.. (1972). Composition and Variation of the Gel Electrophoretic Fractions of Plasma, Cerebrospinal Fluid and Urine. Scandinavian Journal of Clinical and Laboratory Investigation. 29(sup124). 71–82. 85 indexed citations
11.
Kindmark, C.-O. & C.‐B. Laurell. (1972). Sequential Changes of the Plasma Protein Pattern in Inoculation Hepatitis. Scandinavian Journal of Clinical and Laboratory Investigation. 29(sup124). 105–115. 37 indexed citations
12.
Laurell, C.‐B., Stig Kullander, & Jan I. Thorell. (1969). Plasma Proteins after Continuous, Oral Use of a Progestogen—Chloromadionone Acetate—as a Contraceptive. Scandinavian Journal of Clinical and Laboratory Investigation. 24(4). 387–389. 20 indexed citations
13.
Ganrot, P. O., C.‐B. Laurell, & Sten Eriksson. (1967). Obstructive Lung Disease and Trypsin Inhibitors in α 1 -Antitrypsin Deficiency. Scandinavian Journal of Clinical and Laboratory Investigation. 19(3). 205–208. 106 indexed citations
14.
Bachmann, R., C.‐B. Laurell, & E. Svenonius. (1965). Studies on the Serumγ1A-Globulin Level II.γ1A-Deficiency in a case of Systemic Lupus Erythematosus. Scandinavian Journal of Clinical and Laboratory Investigation. 17(1). 46–50. 17 indexed citations
15.
Laurell, C.‐B. & Sten Eriksson. (1963). The Electrophoretic α; 1 -Globulin Pattern of Serum in α; 1 -Antitrypsin Deficiency. Scandinavian Journal of Clinical and Laboratory Investigation. 15(2). 132–140. 1037 indexed citations breakdown →
16.
Laurell, C.‐B.. (1961). Hexose Content of M‐components. Acta Medica Scandinavica. 170(S367). 23–26. 1 indexed citations
17.
Sjöquist, John & C.‐B. Laurell. (1961). N‐Terminal Amino Acids of Isolated M‐components. Acta Medica Scandinavica. 170(S367). 65–68. 5 indexed citations
18.
Laurell, C.‐B.. (1959). Purification and properties of different haptoglobins. Clinica Chimica Acta. 4(1). 79–81. 50 indexed citations
19.
Laurell, C.‐B.. (1959). Determination of the Haptoglobin Group. Scandinavian Journal of Clinical and Laboratory Investigation. 11(1). 18–19. 12 indexed citations
20.
Björkman, Sven, C.‐B. Laurell, & I. M. Nilsson. (1956). Serum Proteins and Fibrinolysis in Polycythemia Vera. Scandinavian Journal of Clinical and Laboratory Investigation. 8(4). 304–308. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026